Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 393-398

  Petit, Steven F ^a   Aerts, Hugo J W L ^a   van Loon, Judith G M ^a   Offermann, Claudia ^a   Houben, Ruud ^a   Winkens, Bjorn ^b   Öllers, Michel C ^a   Lambin, Philippe ^a   De Ruysscher, Dirk ^a   Dekker, André L A J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dose escalation; Dose painting; Lung cancer; NSCLC; Voxel control probability

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG METABOLISM; DRUG UPTAKE; HUMAN; LUNG NON SMALL CELL CANCER; METABOLIC REGULATION; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; RETROSPECTIVE STUDY; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 65649140132     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.02.020     Document Type: Article

References (34)

1. Padhani A.R., Krohn K.A., Lewis J.S., and Alber M. Imaging oxygenation of human tumours. Eur Radiol 17 (2007) 861-872
2. Vaupel P., Schlenger K., Knoop C., and Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51 (1991) 3316-3322
3. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
4. Bentzen S.M. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
5. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
6. Sovik A., Malinen E., and Olsen D.R. Strategies for biologic image-guided dose escalation: a review. Int J Radiat Oncol Biol Phys 73 (2009) 650-658
7. Alber M., Paulsen F., Eschmann S.M., and Machulla H.J. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
8. Das S.K., Miften M.M., Zhou S., et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys 31 (2004) 1452-1461
9. Vanderstraeten B., Duthoy W., De Gersem W., De Neve W., and Thierens H. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 79 (2006) 249-258
10. Sovik A., Malinen E., Skogmo H.K., Bentzen S.M., Bruland O.S., and Olsen D.R. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys 68 (2007) 1496-1504
11. Bentzen S.M. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res 139 (2008) 41-62
12. Tanderup K., Olsen D.R., and Grau C. Dose painting: art or science?. Radiother Oncol 79 (2006) 245-248
13. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
14. Tome W.A., and Fowler J.F. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 48 (2000) 593-599
15. Chen G.P., Ahunbay E., Schultz C., and Li X.A. Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images. Med Phys 34 (2007) 1198-1205
16. Thorwarth D., Eschmann S.M., Paulsen F., and Alber M. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys 68 (2007) 291-300
17. Lin Z., Mechalakos J., Nehmeh S., et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70 (2008) 1219-1228
18. Aerts H.J., Bosmans G., van Baardwijk A.A., et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study. Int J Radiat Oncol Biol Phys 71 (2008) 1402-1407
19. Mac Manus M.P., Hicks R.J., Matthews J.P., Wirth A., Rischin D., and Ball D.L. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 49 (2005) 95-108
20. Poettgen C., Theegarten D., Eberhardt W., et al. Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer. Oncology 73 (2007) 316-323
21. Schutze C., Bergmann R., Yaromina A., et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol 83 (2007) 311-315
22. van Baardwijk A., Bosmans G., Bentzen S.M., et al. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. Int J Radiat Oncol Biol Phys 71 (2008) 1103-1110
23. van Baardwijk A., Bosmans G., Boersma L., et al. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study. Int J Radiat Oncol Biol Phys 71 (2008) 1394-1401
24. Rabe-Hesketh S., Skrondal A., and Pickles A. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J 2 (2002) 1-21
25. max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3 (2008) 6-12
26. Werner-Wasik M., Swann R.S., Bradley J., et al. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 385-390
27. Zhao L., West B.T., Hayman J.A., Lyons S., Cease K., and Kong F.M. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 103-110
28. Willner J., Baier K., Caragiani E., Tschammler A., and Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
29. Klopp A.H., Chang J.Y., Tucker S.L., et al. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys 69 (2007) 1409-1416
30. Moreno-Jimenez M., Aristu J., Lopez-Picazo J.M., et al. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Radiother Oncol 88 (2008) 342-350
31. Rengan R., Rosenzweig K.E., Venkatraman E., et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 741-747
32. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
33. van Baardwijk A., Bosmans G., van Suylen R.J., et al. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiother Oncol 87 (2008) 55-58
34. 18Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 91 (2009) 386-392